Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review
- PMID: 29049756
- PMCID: PMC6178946
- DOI: 10.7326/M17-1361
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review
Abstract
Background: Fecal immunochemical testing is the most commonly used method for colorectal cancer screening worldwide. However, its effectiveness is frequently undermined by failure to obtain follow-up colonoscopy after positive test results.
Purpose: To evaluate interventions to improve rates of follow-up colonoscopy for adults after a positive result on a fecal test (guaiac or immunochemical).
Data sources: English-language studies from the Cochrane Central Register of Controlled Trials, PubMed, and Embase from database inception through June 2017.
Study selection: Randomized and nonrandomized studies reporting an intervention for colonoscopy follow-up of asymptomatic adults with positive fecal test results.
Data extraction: Two reviewers independently extracted data and ranked study quality; 2 rated overall strength of evidence for each category of study type.
Data synthesis: Twenty-three studies were eligible for analysis, including 7 randomized and 16 nonrandomized studies. Three were at low risk of bias. Eleven studies described patient-level interventions (changes to invitation, provision of results or follow-up appointments, and patient navigators), 5 provider-level interventions (reminders or performance data), and 7 system-level interventions (automated referral, precolonoscopy telephone calls, patient registries, and quality improvement efforts). Moderate evidence supported patient navigators and provider reminders or performance data. Evidence for system-level interventions was low. Seventeen studies reported the proportion of test-positive patients who completed colonoscopy compared with a control population, with absolute differences of -7.4 percentage points (95% CI, -19 to 4.3 percentage points) to 25 percentage points (CI, 14 to 35 percentage points).
Limitation: More than half of studies were at high or very high risk of bias; heterogeneous study designs and characteristics precluded meta-analysis.
Conclusion: Patient navigators and giving providers reminders or performance data may help improve colonoscopy rates of asymptomatic adults with positive fecal blood test results. Current evidence about useful system-level interventions is scant and insufficient.
Primary funding source: National Cancer Institute. (PROSPERO: CRD42016048286).
Conflict of interest statement
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Interventions to ensure follow-up of positive fecal immunochemical tests: An international survey of screening programs.J Med Screen. 2021 Mar;28(1):51-53. doi: 10.1177/0969141320904977. Epub 2020 Feb 13. J Med Screen. 2021. PMID: 32054392 Free PMC article.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jun. Report No.: 14-05203-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jun. Report No.: 14-05203-EF-1. PMID: 27441328 Free Books & Documents. Review.
-
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332. JAMA. 2016. PMID: 27305422 Review.
Cited by
-
Optimizing tracking and completion of follow-up colonoscopy after abnormal stool tests at health systems participating in the Centers for Disease Control and Prevention's Colorectal Cancer Control Program.Cancer Causes Control. 2024 Nov;35(11):1467-1476. doi: 10.1007/s10552-024-01898-w. Epub 2024 Aug 6. Cancer Causes Control. 2024. PMID: 39107449
-
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.J Natl Cancer Inst. 2024 Nov 1;116(11):1807-1816. doi: 10.1093/jnci/djae140. J Natl Cancer Inst. 2024. PMID: 39044335 Free PMC article.
-
Perceptions of the Impact of Comorbidity on the Bowel Cancer Screening Programme: Qualitative Study With Bowel Screening Participants and Staff.Health Expect. 2024 Aug;27(4):e14126. doi: 10.1111/hex.14126. Health Expect. 2024. PMID: 38952213 Free PMC article.
-
Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study.J Gen Intern Med. 2024 May 21. doi: 10.1007/s11606-024-08764-0. Online ahead of print. J Gen Intern Med. 2024. PMID: 38771535
-
Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.J Prim Care Community Health. 2024 Jan-Dec;15:21501319241242571. doi: 10.1177/21501319241242571. J Prim Care Community Health. 2024. PMID: 38554066 Free PMC article.
References
-
- Segnan N, Patnick J, von Karsa L. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Luxembourg City, Luxembourg: Publications Office of the European Union; 2010.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical